Skip to main content
Addgene

pcDNA3-ER-CaNAR2
(Plasmid #64732)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 64732 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pcDNA3
  • Backbone manufacturer
    Invitrogen
  • Backbone size w/o insert (bp) 5446
  • Total vector size (bp) 7858
  • Vector type
    Mammalian Expression
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    CYP450-CaNAR2
  • Species
    H. sapiens (human), Synthetic
  • Insert Size (bp)
    2430
  • Promoter CMV
  • Tags / Fusion Proteins
    • Cerulean3 (N terminal on insert)
    • YPet (C terminal on insert)
    • N-terminal 27 amino acids from CYP450 (N terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site HindIII (not destroyed)
  • 3′ cloning site EcoRI (not destroyed)
  • 5′ sequencing primer T7 forward
  • 3′ sequencing primer BGH reverse
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pcDNA3-ER-CaNAR2 was a gift from Jin Zhang (Addgene plasmid # 64732 ; http://n2t.net/addgene:64732 ; RRID:Addgene_64732)
  • For your References section:

    Calmodulin-controlled spatial decoding of oscillatory Ca2+ signals by calcineurin. Mehta S, Aye-Han NN, Ganesan A, Oldach L, Gorshkov K, Zhang J. eLife. 2014 Jul 23;3:e03765. doi: 10.7554/eLife.03765. 10.7554/eLife.03765 PubMed 25056880